LONDON: AstraZeneca, the British maker of a Covid vaccine, said Thursday that group net profit more than doubled last year to $3.2 billion (2.64 billion euros) thanks to strong sales of other medicines.

"Despite the significant impact from the pandemic, we delivered double-digit revenue growth," chief executive Pascal Soriot said in a statement.